Skip to main content

Table 3 DPYD and GSTP1 genes frequency in the study patients

From: Predictive value of clinical toxicities of chemotherapy with fluoropyrimidines and oxaliplatin in colorectal cancer by DPYD and GSTP1 gene polymorphisms

Gene

Genotypes

No. of patients

Percentage (%)

DPYD*2A

WT(GG)

104

100.0

HET(GA)

0

0.0

HOM(AA)

0

0.0

DPYD*5A

WT(AA)

64

61.5

HET(AG)

33

31.7

HOM(GG)

7

6.7

DPYD*9A

WT(TT)

79

76.0

HET(TC)

25

24.0

HOM(CC)

0

0.0

GSTP1

WT(AA)

70

67.3

HET(AG)

31

29.8

HOM(GG)

3

2.9

  1. WT = wild type, HET = heterozygote, HOM = homozygote